ArticleMMWR. Morbidity and mortality weekly report2025

Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025.

Monica E Patton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.